PP_1170x120_10-25-21

NASP

NASP encouraged by Biden Administration’s effort to reduce out-of-pocket drug costs for seniors

NASP encouraged by Biden Administration’s effort to reduce out-of-pocket drug costs for seniors

WASHINGTON — This week, the National Association of Specialty Pharmacy’s president and CEO Sheila Arquette issued comments that laud the Centers for Medicare and Medicaid Services (CMS) for taking steps to reduce out of pocket drug costs for seniors through initial pharmacy Direct and Indirect Remuneration (DIR) reforms. However, NASP urged CMS to do far more

NASP announces scholarship, poster and industry award winners

NASP announces scholarship, poster and industry award winners

WASHINGTON — The National Association of Specialty Pharmacy (NASP) announces the winners of specialty pharmacy’s highly anticipated and coveted scholarship, poster, and specialty pharmacy industry awards. The recipients and winners were announced by Sheila M. Arquette, NASP president & CEO, during a live webinar on December 16, 2021. Though the NASP 2021 Annual Meeting &

Specialty pharmacies call for Congress to act on pharmacy DIR fee reform in budget reconciliation bill

Specialty pharmacies call for Congress to act on pharmacy DIR fee reform in budget reconciliation bill

WASHINGTON — As Congress continues to develop and advance budget reconciliation legislation, specialty pharmacies are alarmed that the House has not included pharmacy direct and indirect (DIR) remuneration fee reform. These rising DIR fees under Medicare Part D are harming specialty pharmacies and their patients who are living with life-altering and life-threatening medical conditions. National

NASP applauds the introduction of bipartisan legislation to reduce drug costs

NASP applauds the introduction of bipartisan legislation to reduce drug costs

WASHINGTON — This week, a bipartisan group of lawmakers in the U.S. House and Senate introduced legislation to rein in the high cost of prescription drugs and support the needs of specialty pharmacy patients living with life-altering and life-threatening specialty medical conditions. The Pharmacy DIR Reform to Reduce Senior Drug Costs Act will ensure that medication

More than 240 patient, health care groups urge congress to reform pharmacy “DIR fees” this year

More than 240 patient, health care groups urge congress to reform pharmacy “DIR fees” this year

WASHINGTON – More than 240 patient advocates and healthcare entities on Friday urged Congressional leaders to act now on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access for vulnerable Americans. “Members of Congress should not overlook the clear and present opportunity to

NACDS, NCPA and NASP release dispensing study

NACDS, NCPA and NASP release dispensing study

WASHINGTON – Pharmacy reimbursement paid by state Medicaid programs requires a fresh look and modernization, according to a new Cost of Dispensing Study commissioned by the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and the National Association of Specialty Pharmacy (NASP).   DOWNLOAD STUDY   DOWNLOAD Q&A   In

Pharmacy united in call for President Trump to act on DIR fee reform

Pharmacy united in call for President Trump to act on DIR fee reform

WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to

Congressman learns about Rx market

Congressman learns about Rx market

GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) got an education on drug cost dynamics during a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Vice chairman of the Problem Solvers Caucus in the House of Representatives, Suozzi said he made the visit to learn more

NASP hails House action on retroactive Part D fees

NASP hails House action on retroactive Part D fees

WASHINGTON — The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers. The lawmakers sent a letter to the Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid

Lawmaker seeks insight on drug cost dilemma

Lawmaker seeks insight on drug cost dilemma

No one claims to hold “the solution” to soaring costs for prescription drugs and how Americans and payers — including government — can afford to pay for them. But strides toward unraveling the tangle of problems behind this issue won’t be made without determined attempts at substantive discussion between the public and private sectors, according

Rep. Tom Suozzi visits N.Y. specialty pharmacy

Rep. Tom Suozzi visits N.Y. specialty pharmacy

GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) gauged cost dynamics of the specialty pharmacy market in a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Seeking insight on what’s driving skyrocketing drug costs and the impact on patients, Suozzi met with Sheila Arquette, executive director

National Association of Specialty Pharmacy moves to new HQ

ALEXANDRIA, Va. — The National Association of Specialty Pharmacy (NASP) has relocated its headquarters to the Washington, D.C., area. NASP said Tuesday that the move is effective immediately. The new headquarters address is 1765 Duke St., Alexandria, Va., 22314. NASP staff have already moved to the new location. The association noted that the new location

Adheris Health